These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25941882)

  • 21. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
    Yuan Z; Gu X
    Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles.
    Tomoda K; Ohkoshi T; Kawai Y; Nishiwaki M; Nakajima T; Makino K
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):138-44. PubMed ID: 17890065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of voriconazole in hospitalised patients.
    Veringa A; Geling S; Span LF; Vermeulen KM; Zijlstra JG; van der Werf TS; Kosterink JG; Alffenaar JC
    Int J Antimicrob Agents; 2017 Feb; 49(2):243-246. PubMed ID: 28012684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice.
    Mondal N; Halder KK; Kamila MM; Debnath MC; Pal TK; Ghosal SK; Sarkar BR; Ganguly S
    Int J Pharm; 2010 Sep; 397(1-2):194-200. PubMed ID: 20609382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension.
    Gupta V; Rawat A; Ahsan F
    J Pharm Sci; 2010 Apr; 99(4):1774-89. PubMed ID: 19894275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
    Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M
    Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles.
    Wu L; Rodríguez-Rodríguez C; Cun D; Yang M; Saatchi K; Häfeli UO
    Eur J Pharm Biopharm; 2020 Jul; 152():108-115. PubMed ID: 32437751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
    Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
    J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
    Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
    Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of voriconazole loaded nanoparticles for parenteral delivery.
    Füredi P; Kovács K; Ludányi K; Antal I; Klebovich I
    Int J Pharm; 2016 Aug; 510(1):159-63. PubMed ID: 27291972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of aerosolized liposomal amphotericin B.
    Lambros MP; Bourne DW; Abbas SA; Johnson DL
    J Pharm Sci; 1997 Sep; 86(9):1066-9. PubMed ID: 9294824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, Metabolism, and Partial Biodistribution of "Pincer Therapeutic" Nitazoxanide in Mice following Pulmonary Delivery of Inhalable Particles.
    Gupta A; Tulsankar SL; Bhatta RS; Misra A
    Mol Pharm; 2017 Apr; 14(4):1204-1211. PubMed ID: 28263078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
    Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
    J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis.
    Gupta M; Vyas SP
    Chem Phys Lipids; 2012 May; 165(4):454-61. PubMed ID: 22309657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
    Sahana DK; Mittal G; Bhardwaj V; Kumar MN
    J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.